Microcrystalline Hydroxyapatite Compound in Prevention of Bone Loss in Corticosteroid-Treated Patients With Chronic Active Hepatitis.

Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.61.719.791
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ